1
|
Garrett T, Tulloch I, McCoy MT, Ladenheim B, Jayanthi S, Krasnova I, Beauvais G, Hodges A, Davis C, Cadet JL. Chronic Methamphetamine Causes Differential Expression of Immediate Early Genes in the Nucleus Accumbens and Midbrain of Rats. JOURNAL OF DRUG AND ALCOHOL RESEARCH 2012; 1:235626. [PMID: 36147517 PMCID: PMC9491698 DOI: 10.4303/jdar/235626] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
The present study investigated whether chronic methamphetamine (METH) would suppress METH-induced mRNA expression of immediate early genes (IEGs) in the rat brain. Rats were given METH or saline over two weeks. After an overnight withdrawal, saline- and METH-pretreated rats received an acute saline or METH challenge. The acute METH challenge increased expression of members of activator protein 1 (AP-1) and Nr4a IEG families in the nucleus accumbens (NAc) and midbrain of saline-pretreated rats. Chronic METH exposure attenuated the effects of acute METH challenge on AP-1 IEG expression in the NAc. However, chronic METH failed to attenuate acute METH-induced increases of Nr4a1 and Nr4a3 expression in the NAc. In contrast to observations in the NAc, chronic METH did not prevent acute METH-induced changes in IEG expression in the midbrain. These results suggest that these two brain regions that are implicated in neuroplastic effects of illicit substances might be differentially affected by psychostimulants.
Collapse
Affiliation(s)
- Tiffany Garrett
- Molecular Neuropsychiatry Branch, DHHS/NIH/NIDA-Intramural Research Program, 251 Bayview Blvd, Baltimore, MD 21224, USA
| | - Ingrid Tulloch
- Molecular Neuropsychiatry Branch, DHHS/NIH/NIDA-Intramural Research Program, 251 Bayview Blvd, Baltimore, MD 21224, USA
| | - Michael T McCoy
- Molecular Neuropsychiatry Branch, DHHS/NIH/NIDA-Intramural Research Program, 251 Bayview Blvd, Baltimore, MD 21224, USA
| | - Bruce Ladenheim
- Molecular Neuropsychiatry Branch, DHHS/NIH/NIDA-Intramural Research Program, 251 Bayview Blvd, Baltimore, MD 21224, USA
| | - Subramaniam Jayanthi
- Molecular Neuropsychiatry Branch, DHHS/NIH/NIDA-Intramural Research Program, 251 Bayview Blvd, Baltimore, MD 21224, USA
| | - Irina Krasnova
- Molecular Neuropsychiatry Branch, DHHS/NIH/NIDA-Intramural Research Program, 251 Bayview Blvd, Baltimore, MD 21224, USA
| | - Genevieve Beauvais
- Molecular Neuropsychiatry Branch, DHHS/NIH/NIDA-Intramural Research Program, 251 Bayview Blvd, Baltimore, MD 21224, USA
| | - Amber Hodges
- Molecular Neuropsychiatry Branch, DHHS/NIH/NIDA-Intramural Research Program, 251 Bayview Blvd, Baltimore, MD 21224, USA
| | - Carolyn Davis
- Molecular Neuropsychiatry Branch, DHHS/NIH/NIDA-Intramural Research Program, 251 Bayview Blvd, Baltimore, MD 21224, USA
| | - Jean Lud Cadet
- Molecular Neuropsychiatry Branch, DHHS/NIH/NIDA-Intramural Research Program, 251 Bayview Blvd, Baltimore, MD 21224, USA
| |
Collapse
|
2
|
Dopamine D1, D2 and mu-opioid receptors are co-expressed with adenylyl cyclase 5 and phosphodiesterase 7B mRNAs in striatal rat cells. Brain Res 2009; 1310:37-45. [PMID: 19913519 DOI: 10.1016/j.brainres.2009.11.009] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2009] [Revised: 11/03/2009] [Accepted: 11/05/2009] [Indexed: 01/04/2023]
Abstract
Intracellular cAMP levels are regulated by cAMP synthesis and degradation rate. Nine isoforms of cAMP-synthesizing enzymes called adenylyl-cyclases (ACs) and eleven phosphodiesterases (PDEs) that degrade cyclic nucleotides have been identified. Both types of enzymes exhibit variations not only in their expression pattern distribution throughout the brain, but also in their regulatory characteristics. Different isoforms of ACs and PDEs may be co-expressed in a single cell, thus a gradient of cAMP intracellular levels is formed, which accounts for the diversity of cell responses. Among these isoforms, AC5 and PDE7B are highly expressed in striatum, where the cAMP pathway is implicated in diverse behavioural functions. Striatal AC5 is involved in drug reinforcing actions and motor activity. Less is known about the role of the PDE7B isoenzyme. We performed a double in situ hybridization analysis of the co-expression patterns of AC5 and PDE7B with mu-opioid-receptor (MOR), D1- and D2-receptor mRNAs to contribute to a better understanding in the regulation of cAMP levels under dopamine or opioidergic pathway activation in striatum. We found co-expression of AC5 and PDE7B mRNAs in caudate-putamen and nucleus accumbens; we also encountered that more than 50% of MOR, D2- and D1-expressing cells contained AC5 and PDE7B mRNAs. The presence of AC5 and PDE7B mRNAs in D1- and D2-containing cells suggests the participation of these enzymes in striatal functions involving dopaminergic pathways. Co-localization of both isoenzyme mRNAs with MOR expressing cells suggests their involvement in opioid reinforcing effects.
Collapse
|
3
|
Ferguson SM, Norton CS, Watson SJ, Akil H, Robinson TE. Amphetamine-evoked c-fos mRNA expression in the caudate-putamen: the effects of DA and NMDA receptor antagonists vary as a function of neuronal phenotype and environmental context. J Neurochem 2003; 86:33-44. [PMID: 12807422 DOI: 10.1046/j.1471-4159.2003.01815.x] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Dopamine (DA) and glutamate neurotransmission is thought to be critical for psychostimulant drugs to induce immediate early genes (IEGs) in the caudate-putamen (CPu). We report here, however, that the ability of DA and glutamate NMDA receptor antagonists to attenuate amphetamine-evoked c-fos mRNA expression in the CPu depends on environmental context. When given in the home cage, amphetamine induced c-fos mRNA expression predominately in preprodynorphin and preprotachykinin mRNA-containing neurons (Dyn-SP+ cells) in the CPu. In this condition, all of the D1R, D2R and NMDAR antagonists tested dose-dependently decreased c-fos expression in Dyn-SP+ cells. When given in a novel environment, amphetamine induced c-fos mRNA in both Dyn-SP+ and preproenkephalin mRNA-containing neurons (Enk+ cells). In this condition, D1R and non-selective NMDAR antagonists dose-dependently decreased c-fos expression in Dyn-SP+ cells, but neither D2R nor NR2B-selective NMDAR antagonists had no effect. Furthermore, amphetamine-evoked c-fos expression in Enk+ cells was most sensitive to DAR and NMDAR antagonism; the lowest dose of every antagonist tested significantly decreased c-fos expression only in these cells. Finally, novelty-stress also induced c-fos expression in both Dyn-SP+ and Enk+ cells, and this was relatively resistant to all but D1R antagonists. We suggest that the mechanism(s) by which amphetamine evokes c-fos expression in the CPu varies depending on the stimulus (amphetamine vs. stress), the striatal cell population engaged (Dyn-SP+ vs. Enk+ cells), and environmental context (home vs. novel cage).
Collapse
Affiliation(s)
- Susan M Ferguson
- Neuroscience Program, University of Michigan, Ann Arbor 48109, USA
| | | | | | | | | |
Collapse
|